A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules
نویسندگان
چکیده
Abstract Background Lung cancer remains the leading cause of deaths across world. Early detection lung by low-dose computed tomography (LDCT) can reduce mortality rate. However, making a definitive preoperative diagnosis malignant pulmonary nodules (PNs) found LDCT is clinical challenge. This study aimed to develop prediction model based on DNA methylation biomarkers and radiological characteristics for identifying from benign PNs. Methods We assessed three ( PTGER4 , RASSF1A, SHOX2 ) clinically-relevant variables in training cohort 110 individuals with Four machine-learning-based models were established compared, including K-nearest neighbors (KNN), random forest (RF), support vector machine (SVM), logistic regression (LR) algorithms. Variables best-performing algorithm selected through stepwise use Akaike’s information criterion (AIC). The constructed was compared Mayo Clinic using non-parametric approach DeLong et al. area under receiver operator characteristic curve (AUC) analysis. Results A finally one developed achieved an AUC value 0.951 PNs diagnosis, significantly higher than (0.912, 95% CI:0.843–0.958, p = 0.013) or (0.823, CI:0.739–0.890, 0.001). Validation testing 100 subjects confirmed diagnostic value. Conclusion have shown that integrating could more accurately identify CT-found our may provide utility combination improve over-all cancer.
منابع مشابه
The Value of LDH Level of BAL Fluid in Differentiating Benign from Malignant Solitary Pulmonary Nodules
Background: Serum lactate dehydrogenase (LDH) concentration is an indicator for tissue injury. It may be secreted locally in many conditions. For the first time, this study was performed to investigate the value of LDH level in bronchoalveolar lavage fluid (BALF) in differentiation of benign from malignant single pulmonary nodules (SPNs) and to assess its relationship with serum LDH levels. Met...
متن کاملDistinguishing Benign from Malignant Nodules
L ung cancer causes more cancer-related deaths in the United States than any other malignancy. Two facts account for this disturbing observation. The incidence of lung cancer in both men and women has progressively increased in recent years. Treatment of lung cancer remains largely ineffective. The overall 5-year survival rate for patients with lung cancer may be as low as 7 percent to 14 perce...
متن کاملMetabolic Profiling of Plasma from Benign and Malignant Pulmonary Nodules Patients Using Mass Spectrometry-Based Metabolomics
Solitary pulmonary nodule (SPN or coin lesion) is a mass in the lung and can be commonly found in chest X-rays or computerized tomography (CT) scans. However, despite the advancement of imaging technologies, it is still difficult to distinguish malignant cancer from benign SPNs. Here we investigated the metabolic profiling of patients with benign and malignant pulmonary nodules. A combination o...
متن کاملDNA-methylation profiling distinguishes malignant melanomas from benign nevi
DNA methylation, an epigenetic alteration typically occurring early in cancer development, could aid in the molecular diagnosis of melanoma. We determined technical feasibility for high-throughput DNA-methylation array-based profiling using formalin-fixed paraffin-embedded tissues for selection of candidate DNA-methylation differences between melanomas and nevi. Promoter methylation was evaluat...
متن کاملMulti‐slice computed tomography characteristics of solitary pulmonary ground‐glass nodules: Differences between malignant and benign
BACKGROUND Ground-glass nodules (GGNs), which are possible precursors of lung cancer, attract increasing attention. Many studies have attempted to identify the characteristic imaging features of GGNs for their qualitative diagnosis; however, the comprehension of GGNs remains controversial. We performed this study to identify imaging characteristics helpful to the differential diagnosis of solit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Cancer
سال: 2021
ISSN: ['1471-2407']
DOI: https://doi.org/10.1186/s12885-021-08002-4